Indegene Receives Frost & Sullivan 2026 Global AI Pharma Leadership Recognition
Indegene Ltd 路 Press Release 路 22 Oct 2026, 4:07 pm
Indegene Receives Frost & Sullivan 2026 Global AI Pharma Leadership Recognition Indegene has received Frost & Sullivan鈥檚 2026 Global Enabling Technology Leadership Recognition for AI-powered pharma commercialization services on 22nd Oct'26. The recognition highlights Indegene's strategy effectiveness, execution scale, and proprietary solutions like its Pharma Operating System and Cortex reasoning engine across commercial, medical, regulatory, and analytics workflows. Currently trusted by the world's top 20 biopharma companies, the recognition validates Indegene鈥檚 competitive positioning, enterprise generative AI capabilities, and domain-led operating model within the global life sciences technology and commercialization landscape.
Original exchange filing (PDF)
More announcements from Indegene Ltd
- Intimation of Investors / Analysts Meeting 路 06 Nov 2026
- Transcript of the Q2 FY27 Earnings Call 路 04 Nov 2026
- Audio Recording of the Q2 FY27 Earnings Call 路 30 Oct 2026
- Audio Recording of the Q2 FY27 Earnings Call 路 30 Oct 2026
- Analyst Presentation and Fact Sheet - financial results for the 2nd quarter and half year ended 30th September, 2026 路 30 Oct 2026
- Press Release 路 30 Oct 2026
- Indegene Limited has informed the Exchange regarding Resignation of Ms Srishti Ramesh Kaushik as Company Secretary & Compliance Officer of the company w.e.f. December 02, 2026. 路 30 Oct 2026
- Intimation of Resignation of Ms. Srishti Ramesh Kaushik (M. No A21609) from the position of Company Secretary, Compliance Officer and Key Managerial Personnel of the Company. 路 30 Oct 2026
